Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Search

Reset Filter
You have a filtered search result

32 search results for ‘*’


Disease Area Metabolism & Diabetes

Tackling the Fatty-Liver Timebomb

| Jonathan James

Could modulation of fibroblast growth factor 21 translate into a new treatment for non-alcoholic fatty liver disease?


Research Field Biomedical engineering

Corneal Construction

| Jonathan James

Researchers fine-tune 3D printing technology to create better biomimetic corneas – and predict a “breakthrough” in global transplantation practice.


Tools & Techniques Omics

A Microbial Map to Cancer

| Michael Schubert

A new study uses machine learning to perform meta-analysis of eight metagenomic studies linking gut microbial signatures with colorectal cancer.


Tools & Techniques Imaging

IVF ID

| Jonathan James

Artificial intelligence holds the key to improving embryo selection for in vitro fertilization.


Research Field Nanomedicine

Rewriting the Cancer Code

| Jonathan James

Scientists are targeting cancer’s “housekeeping” genes with biological nanomachines


Disease Area Cancer

Two-pronged Attack on Neuroblastoma

| Jonathan James

How inhibiting both polyamine synthesis (with DFMO) and uptake (with new small molecule AMXT 1501) could delay tumor development.


Tools & Techniques Diagnostics & prognostics

Biomarkers Beyond Our Wildest Dreams

| Luke Turner

Different glycosylation patterns in patients with idiopathic REM sleep behavior disorder could predict the future onset of neurodegenerative disease.


Tools & Techniques Diagnostics & prognostics

Getting to the Heart of the Matter

| Jonathan James

How a combinatorial approach to assessing coronary heart disease could improve diagnosis.


Disease Area Cancer

Adaptive Invaders

| Jonathan James

New evidence suggests there’s more to metastasis than MMPs, demanding a therapeutic rethink.


Disease Area Metabolism & Diabetes

Bite-size Breakthroughs: IELS, Imaging and Ocular Cancer

| Jonathan James

The latest advances in translational medicine – condensed into 20-second servings.


Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register